Changes of cerebrospinal fluid tumor marker levels may predict response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer

Author： Kosmas Christos   Tsavaris Nicolas   Soukouli Georgia   Gouveris Panagiotis   Tsakonas George   Katselis John   Alexopoulos Heraklis   Mylonakis Nicolas   Karabelis Athanasios  

Publisher： Humana Press, Inc

ISSN： 1357-0560

Source： Medical Oncology, Vol.22, Iss.2, 2005-06, pp. : 123-128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Biomarkers of disease: cerebrospinal fluid vascular endothelial growth factor (VEGF) and stromal cell derived factor (SDF)-1 levels in patients with neoplastic meningitis (NM) due to breast cancer, lung cancer and melanoma

By Groves Morris   Hess Kenneth   Puduvalli Vinay   Colman Howard   Conrad Charles   Gilbert Mark   Weinberg Jeffrey   Cristofanilli Massimo   Yung W.   Liu Ta-Jen  

Journal of Neuro-Oncology, Vol. 94, Iss. 2, 2009-09 ,pp. : 229-234

Springer Publishing Company

Access to resources Recommend Favorite

HER-2/Neu overexpression does not predict response to neoadjuvant chemotherapy or prognosticate survival in patients with locally advanced breast cancer

By Tulbah Asma   Ibrahim Ezzeldin   Ezzat Adnan   Ajarim Dahish   Rahal Mohammed   Weshi Amr   Sorbris Ralph  

Medical Oncology, Vol. 19, Iss. 1, 2002-03 ,pp. : 15-23

Humana Press, Inc

Access to resources Recommend Favorite

Erythropoietin enhances response to treatment in patients with advanced breast cancer

By Larsson Anna-Maria   Landberg Göran   Påhlman Sven   Albertsson Maria  

Acta Oncologica, Vol. 43, Iss. 6, 2004-09 ,pp. : 594-597

Informa Healthcare

Access to resources Recommend Favorite

Psychological factors can predict the response to primary chemotherapy in patients with locally advanced breast cancer - report of a feasibility study

By Walker L.G.   Heys S.D.   Walker M.B.   Ogston K.   Miller I.D.   Hutcheon A.W.   Sarkar T.K.   Ah-See A.K.   Eremin O.  

European Journal of Cancer, Vol. 35, Iss. 13, 1999-12 ,pp. : 1783-1788

Elsevier

Access to resources Recommend Favorite

Tumor marker levels elevate false-positively in postsurgical Breast Cancer patients with high sgpt levels or with receiving oral 5-FU or its derivatives

By Asanuma Kazuhiko   Hama Yoshihisa   Kobayashi Shinya   Shingu Kiyoshi   Yokoyama Shiro   Fujimori Minoru   Kasuga Yoshio   Amano Jun  

Breast Cancer, Vol. 6, Iss. 3, 1999-07 ,pp. : 181-186

Springer Publishing Company

Access to resources Recommend Favorite